Publication | Closed Access
A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): Results of the CONKO 004 trial
70
Citations
0
References
2009
Year
Surgical OncologyConko 004Cancer ManagementPathologyPharmacotherapyMay 30OncologyPancreatic CancerClinical TrialsClinical OncologyRandomized TrialRadiation OncologyMolecular OncologyCancer ResearchFinal TextHealth SciencesAdvanced Pancreatic CancerCancer TreatmentPharmacologyMalignant DiseaseTumoral PathologyMedicine
LBA4506 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings, distributed onsite at the Meeting on May 30, 2009, and as a supplement to the June 20, 2009, issue of the Journal of Clinical Oncology. No significant financial relationships to disclose.